HM Payson & Co. Buys 8,904 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

HM Payson & Co. boosted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 5.3% in the first quarter, according to its most recent filing with the SEC. The firm owned 175,706 shares of the medical research company's stock after acquiring an additional 8,904 shares during the period. Thermo Fisher Scientific accounts for 1.5% of HM Payson & Co.'s portfolio, making the stock its 21st largest position. HM Payson & Co.'s holdings in Thermo Fisher Scientific were worth $87,431,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Bernard Wealth Management Corp. bought a new position in shares of Thermo Fisher Scientific during the fourth quarter worth $25,000. Pillar Financial Advisors LLC bought a new stake in Thermo Fisher Scientific in the 4th quarter valued at $29,000. Ameriflex Group Inc. bought a new stake in Thermo Fisher Scientific in the 4th quarter valued at $30,000. Cassady Schiller Wealth Management LLC lifted its position in Thermo Fisher Scientific by 89.2% in the 4th quarter. Cassady Schiller Wealth Management LLC now owns 70 shares of the medical research company's stock valued at $36,000 after acquiring an additional 33 shares in the last quarter. Finally, VSM Wealth Advisory LLC bought a new stake in Thermo Fisher Scientific in the 4th quarter valued at $36,000. Institutional investors and hedge funds own 89.23% of the company's stock.

Insider Transactions at Thermo Fisher Scientific

In related news, EVP Gianluca Pettiti sold 300 shares of the firm's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $429.93, for a total transaction of $128,979.00. Following the completion of the sale, the executive vice president owned 23,167 shares in the company, valued at approximately $9,960,188.31. This trade represents a 1.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.33% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on TMO. Robert W. Baird cut their price objective on shares of Thermo Fisher Scientific from $603.00 to $573.00 and set an "outperform" rating on the stock in a research report on Thursday, April 24th. Wells Fargo & Company lowered their price objective on shares of Thermo Fisher Scientific from $580.00 to $570.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Barclays decreased their price target on shares of Thermo Fisher Scientific from $475.00 to $450.00 and set an "equal weight" rating on the stock in a research note on Tuesday, June 24th. Wall Street Zen upgraded shares of Thermo Fisher Scientific from a "hold" rating to a "buy" rating in a research report on Wednesday, May 21st. Finally, The Goldman Sachs Group set a $610.00 price target on shares of Thermo Fisher Scientific and gave the stock a "buy" rating in a report on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $604.05.

Thermo Fisher Scientific Stock Up 0.1%

Shares of TMO traded up $0.49 during trading hours on Friday, reaching $428.25. 1,359,321 shares of the stock traded hands, compared to its average volume of 1,974,470. The company has a current ratio of 1.77, a quick ratio of 1.38 and a debt-to-equity ratio of 0.64. The stock has a fifty day simple moving average of $409.18 and a 200 day simple moving average of $479.90. Thermo Fisher Scientific Inc. has a 52 week low of $385.46 and a 52 week high of $627.88. The company has a market cap of $161.66 billion, a price-to-earnings ratio of 19.60, a PEG ratio of 2.28 and a beta of 0.77.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The medical research company reported $5.15 earnings per share for the quarter, beating analysts' consensus estimates of $5.10 by $0.05. Thermo Fisher Scientific had a net margin of 15.19% and a return on equity of 17.15%. The company had revenue of $10.36 billion for the quarter, compared to analyst estimates of $10.23 billion. During the same period last year, the firm earned $5.11 earnings per share. The firm's revenue was up .2% on a year-over-year basis. On average, equities analysts forecast that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.

Thermo Fisher Scientific Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Friday, June 13th will be issued a dividend of $0.43 per share. The ex-dividend date is Friday, June 13th. This represents a $1.72 dividend on an annualized basis and a yield of 0.40%. Thermo Fisher Scientific's dividend payout ratio (DPR) is presently 10.09%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.